Cis-regulatory functions of overlapping HIF-1alpha/E-box/AP-1-like sequences of CD164

BMC Molecular Biology

Volumn 12, Issue , 2011, Pages

  Tang, Jingqun ^a,c   Luo, Zhaohui ^b   Zhou, Guangqian ^d   Song, Chao ^c   Yu, Fenglei ^a   Xiang, Juanjuan ^b,c   Li, Gang ^e,f  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d Shenzhen University School of Medicine   (China)

^e Prince of Wales Hospital   (Hong Kong)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD164 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

5' UNTRANSLATED REGION; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CIS REGULATORY ELEMENT; COMPUTER MODEL; DNA FLANKING REGION; E BOX ELEMENT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; MUTATION; PLASMID; PROMOTER REGION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL LINE; CHEMISTRY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; REPORTER GENE; TRANSCRIPTION INITIATION;

ANTIGENS, CD164; BASE SEQUENCE; BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 80054006537     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-12-44     Document Type: Article

References (26)

1. Zhou GQ, Zhang Y, Ferguson DJ, Chen S, Rasmuson-Lestander A, Campbell FC, Watt SM. The Drosophila ortholog of the endolysosomal membrane protein, endolyn, regulates cell proliferation. Journal of cellular biochemistry 2006, 99(5):1380-1396. 10.1002/jcb.20965, 16924678.
2. Zannettino AC, Buhring HJ, Niutta S, Watt SM, Benton MA, Simmons PJ. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 1998, 92(8):2613-2628.
3. Chan JY, Lee-Prudhoe JE, Jorgensen B, Ihrke G, Doyonnas R, Zannettino AC, Buckle VJ, Ward CJ, Simmons PJ, Watt SM. Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn. J Biol Chem 2001, 276(3):2139-2152. 10.1074/jbc.M007965200, 11027692.
4. Kurosawa N, Kanemitsu Y, Matsui T, Shimada K, Ishihama H, Muramatsu T. Genomic analysis of a murine cell-surface sialomucin, MGC-24/CD164. Eur J Biochem 1999, 265(1):466-472. 10.1046/j.1432-1327.1999.00777.x, 10491205.
5. Ihrke G, Gray SR, Luzio JP. Endolyn is a mucin-like type I membrane protein targeted to lysosomes by its cytoplasmic tail. Biochem J 2000, 345 Pt 2:287-296. 1220758, 10620506.
6. Watt SM, Chan JY. CD164--a novel sialomucin on CD34+ cells. Leuk Lymphoma 2000, 37(1-2):1-25. 10.3109/10428190009057625, 10721766.
7. Watt SM, Buhring HJ, Rappold I, Chan JY, Lee-Prudhoe J, Jones T, Zannettino AC, Simmons PJ, Doyonnas R, Sheer D, et al. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998, 92(3):849-866.
8. Lee YN, Kang JS, Krauss RS. Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast. Molecular and cellular biology 2001, 21(22):7696-7706. 10.1128/MCB.21.22.7696-7706.2001, 99940, 11604505.
9. Vaday GG, Hua SB, Peehl DM, Pauling MH, Lin YH, Zhu L, Lawrence DM, Foda HD, Zucker S. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies. Clin Cancer Res 2004, 10(16):5630-5639. 10.1158/1078-0432.CCR-03-0633, 15328206.
10. Masuzawa Y, Miyauchi T, Hamanoue M, Ando S, Yoshida J, Takao S, Shimazu H, Adachi M, Muramatsu T. A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression. Journal of biochemistry 1992, 112(5):609-615.
11. Havens AM, Jung Y, Sun YX, Wang J, Shah RB, Buhring HJ, Pienta KJ, Taichman RS. The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 2006, 6:195. 10.1186/1471-2407-6-195, 1557671, 16859559.
12. Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M, Stow P, Su X, Shurtleff S, Pui CH, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 2011, 117(23):6267-6276. 10.1182/blood-2010-12-324004, 21487112.
13. Matsui T, Kurosawa N, Hibi K, Akiyama S, Kasai Y, Sakamoto J, Ito K, Nakao A, Muramatsu T. The ratio of splicing variants of MGC-24/CD164, a sialomucin, correlates with the metastatic potential of colorectal carcinomas. Journal of biochemistry 2000, 127(6):1103-1107.
14. Knudsen S. Promoter2.0: for the recognition of PolII promoter sequences. Bioinformatics 1999, 15(5):356-361. 10.1093/bioinformatics/15.5.356, 10366655.
15. Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics 1999, 15(7-8):622-630.
16. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003, 3(11):859-868. 10.1038/nrc1209, 14668816.
17. Cambi F, Fung B, Chikaraishi D. 5' flanking DNA sequences direct cell-specific expression of rat tyrosine hydroxylase. J Neurochem 1989, 53(5):1656-1659. 10.1111/j.1471-4159.1989.tb08567.x, 2571679.
18. Douglass J, McMurray CT, Garrett JE, Adelman JP, Calavetta L. Characterization of the rat prodynorphin gene. Mol Endocrinol 1989, 3(12):2070-2078. 10.1210/mend-3-12-2070, 2628741.
19. Comb M, Birnberg NC, Seasholtz A, Herbert E, Goodman HM. A cyclic AMP- and phorbol ester-inducible DNA element. Nature 1986, 323(6086):353-356. 10.1038/323353a0, 3020428.
20. Masood K, Besnard F, Su Y, Brenner M. Analysis of a segment of the human glial fibrillary acidic protein gene that directs astrocyte-specific transcription. J Neurochem 1993, 61(1):160-166. 10.1111/j.1471-4159.1993.tb03551.x, 8515262.
21. Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK, et al. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 2002, 21(50):7680-7689. 10.1038/sj.onc.1205883, 12400010.
22. Park YG, Nesterova M, Agrawal S, Cho-Chung YS. Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth. J Biol Chem 1999, 274(3):1573-1580. 10.1074/jbc.274.3.1573, 9880535.
23. Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M, Wagner EF. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 2003, 112(2):181-192. 10.1016/S0092-8674(03)00042-4, 12553907.
24. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4(5):E131-136. 10.1038/ncb0502-e131, 11988758.
25. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999, 13(5):607-619. 10.1101/gad.13.5.607, 316508, 10072388.
26. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. Embo J 1994, 13(13):3094-3103. 395200, 8039503.